Cytokine-mediated hypersensitivity reactions to carboplatin in early triple-negative breast cancer with neoadjuvant pembrolizumab plus chemotherapy

Authors
Category Primary study
Conference2025 ASCO Annual Meeting I
Year 2025
This article has no abstract
Epistemonikos ID: bfba0f6f930a998efd07c88a62c7012c429d5541
First added on: Sep 03, 2025